[Transitional symptoms, adverse effects and incidents in hormone-substitution therapy].
Patients underlying the permanent endocrine substitution need a particular control and a competent conduction on account of their endangering by intercurrent events. Highly specialised knowledge of the physician and intensive collaboration of the patient from this reciprocity lead to essential aspects of the prophylaxis of the crisis-like exacerbations exhibited in detail. The optimum substitution is supplemented by issuing information and emergency cards. When the patient possesses such cards they will become of decisive importance in an urgent therapy necessary outside the controlling facility.
D001127:Arginine Vasopressin / Q000009:adverse effects*; D001929:Brain Edema / Q000139:chemically induced; D003919:Diabetes Insipidus / Q000188:drug therapy; D004097:Dihydrotachysterol / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000009:adverse effects* / Q000627:therapeutic use; D007011:Hypoparathyroidism / Q000188:drug therapy; D007037:Hypothyroidism / Q000188:drug therapy; D009120:Muscle Cramp / Q000139:chemically induced; D010900:Pituitary Diseases / Q000188:drug therapy; D013963:Thyroid Hormones / Q000009:adverse effects* / Q000627:therapeutic use; D014667:Vasopressins / Q000031:analogs & derivatives*
D013963:Thyroid Hormones; D014667:Vasopressins; D001127:Arginine Vasopressin; D004097:Dihydrotachysterol; D006854:Hydrocortisone
Durchgangssymptome, Nebenwirkungen und Zwischenfälle bei hormonsubstituierender Therapie